Location History:
- Telford, PA (US) (1995 - 2000)
- Perkasie, PA (US) (2001 - 2003)
- Perkasie, NJ (US) (2011)
- Sellersville, PA (US) (2009 - 2013)
Company Filing History:
Years Active: 1995-2013
Title: The Innovative Contributions of Jeffrey M. Bergman
Introduction
Jeffrey M. Bergman, based in Sellersville, PA, is a prolific inventor with a remarkable portfolio of 21 patents. His work primarily focuses on advancements in pharmaceutical compounds, particularly those that target orexin receptors, offering potential treatments for various neurological and psychiatric disorders.
Latest Patents
Among his latest patents are two significant inventions:
1. **Isonicotinamide Orexin Receptor Antagonists** - This invention addresses isonicotinamide compounds that act as antagonists of orexin receptors. These compounds hold promise in treating or preventing neurological and psychiatric disorders associated with orexin receptors. The patent also covers pharmaceutical compositions containing these compounds and their potential applications in clinical settings.
2. **2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists** - Similar to the first, this invention relates to 2,5-disubstituted phenyl carboxamide compounds functioning as orexin receptor antagonists. The focus remains on utilizing these compounds for therapeutic interventions in neurological and psychiatric conditions linked to orexin receptor activity.
Career Highlights
Throughout his career, Jeffrey has made significant contributions while working with leading pharmaceutical companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His expertise and innovative spirit have played a vital role in developing groundbreaking therapeutic solutions in the pharmaceutical industry.
Collaborations
Jeffrey M. Bergman has collaborated with notable peers in his field, including Christopher J. Dinsmore and Paul J. Coleman. These collaborations highlight the importance of teamwork in the innovation process and the shared goal of advancing medical treatments through scientific discovery.
Conclusion
With a strong focus on orexin receptor antagonists, Jeffrey M. Bergman exemplifies the spirit of innovation in the pharmaceutical field. His contributions assert the potential for enhancing treatment options for individuals facing neurological and psychiatric difficulties, ultimately making a positive impact on public health. Through his patents, Jeffrey continues to push the boundaries of science and technology, paving the way for future advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.